FewerJobs.
Employers

Employer profile

Braveheart

6 open roles indexed with location, benefit, and apply-link signals where available.

Employer site ATS: greenhouse Top-startup signal

Open roles

Showing the most recent indexed roles for this employer.

Search all matching jobs
  • Director/Senior Director, Clinical Quality

    San Francisco, CA or Remote or Hybrid

    hybrid $200K-$290K

    Director/Senior Director, Clinical Quality San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The Director/Senior Director of Clinical Quality will serve as a senior quality leader for Braveheart Bio and will be responsible for clinical quality oversight and for maintaining a state of inspection readiness for our late-stage clinical program in hypertrophic cardiomyopathy (HCM). Reporting to the Vice President, Quality, this individual will establish and execute the clinical oversight framework to support global Phase 3 execution, guide clinical development teams, and prepare the organization for future regulatory submissions and commercialization activities. This leader will partner closely with Clinical Operations, Regulatory, Biometrics, Pharmacovigilance, and external CRO and vendor partners to ensure best-in-class quality oversight across all programs. The Director/Senior Director may also build and lead a small quality team as Braveheart grows. This is a hands-on,

  • (Senior) Director, Regulatory Affairs CMC

    San Francisco, CA or Remote or Hybrid

    hybrid $210K-$305K

    (Senior) Director, Regulatory Affairs CMC San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The (Senior) Director, Regulatory Affairs CMC will serve as the Global CMC Regulatory Lead and provide regulatory CMC leadership for Braveheart Bio's HCM program. Reporting to the Vice President of Regulatory Affairs, this hands-on individual contributor will develop and execute the global CMC regulatory strategy that carries our lead asset from Phase 3 through registration, launch supply, and lifecycle management. This role will play a central part in building a CMC data package that meets FDA and international expectations and in preparing the company for commercial launch. This role will also help build the CMC regulatory processes and infrastructure as Braveheart continues to scale. This is an exciting opportunity to join a regulatory function at a pivotal stage in Braveheart's development

  • Associate Director, Clinical Science

    San Francisco, CA or Remote or Hybrid

    hybrid $180K-$240K

    Associate Director, Clinical Science San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The Associate Director, Clinical Science will serve as a key scientific contributor within Braveheart Bio's Clinical Development organization, partnering closely with the Clinical Development Medical Directors to shape and execute the clinical and translational science strategy for BHB-1893 across the hypertrophic cardiomyopathy spectrum (oHCM and nHCM). This role will play a critical part in preparing BHB-1893 for global Phase 3 execution and regulatory submissions. The Associate Director, Clinical Science will provide scientific leadership for protocol design and endpoint strategy, clinical data review and quality, independent analysis of clinical, biomarker, and exploratory endpoint data, and the scientific content of clinical study reports, publications, and regulatory documents. Working cross-functionally with Biometrics, Clinical Pharmacology, Data Management, and Clinical Operations, this individual will translate complex datasets

  • Senior Manager, Regulatory Affairs

    San Francisco, CA or Remote or Hybrid

    hybrid $170K-$195K

    Senior Manager, Regulatory Affairs San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The Senior Manager, Regulatory Affairs will play a key role in Braveheart Bio's global regulatory submissions, spanning U.S. IND and NDA activities and ex-U.S. CTA and MAA activities. Reporting to the Vice President of Regulatory Affairs, this individual will prepare and manage submissions to global health authorities and help develop and execute regulatory strategy. The role requires strong knowledge of U.S. FDA regulations (21 CFR Parts 312 and 314), the EU Clinical Trials Regulation (EU CTR 536/2014), and hands-on experience navigating country-specific requirements in regions outside the U.S. This is an exciting opportunity to join the regulatory function at a pivotal stage in Braveheart's development and make a direct impact on the company's path to global development. The ideal candidate brings strong

  • Associate Director, Quality (Clinical)

    San Francisco, CA or Remote or Hybrid

    hybrid $175K-$210K

    Associate Director, Quality (Clinical) San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The Associate Director, Quality owns clinical and nonclinical quality oversight for assigned studies, vendors, and workstreams from end to end, and serves as a senior quality advisor across Braveheart Bio's clinical programs. Reporting to the Director, Quality, this individual will make quality decisions within scope, serve as the primary quality contact for assigned vendors and CROs, and direct the work of contractors or junior staff. Key responsibilities: Quality Strategy & Leadership - Applies clinical quality strategy for assigned studies and workstreams, aligned with global regulatory requirements and risk-based quality principles - Serves as a trusted quality partner to clinical teams, proactively identifying, assessing, and mitigating risk - Serves as GCP subject matter expert for assigned programs Study-Level Quality Oversight - Develops and

  • Clinical Trial Manager

    San Francisco, CA or Remote or Hybrid

    hybrid $140K-$170K

    Clinical Trial Manager San Francisco, CA or Remote or Hybrid About us: Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart's goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area. The role: The C linical Trial Manager (CTM) is a key member of the Clinical Operations team and will report into the Clinical Program Manager , Clinical Operations , partnering closely on the start-up and initiation of a global Phase 3 program. The primary responsibilit ie s of the CTM will be regional study management of the EU and vendor management . Key responsibilities: - With guidance from the Clinical Program Manager, ClinOps, responsibility for day-to-day activities within a region or regions, including site selection, start-up, maintenance, and close-out activities. With guidance, may serve as the key operational contact for Braveheart Bio studies aiding in site selection, study implementation, and ongoing coordination of study sites, either directly or via CROs. - Assist Clinical Program Manager,